Rock Creek Group’s Twist Bioscience TWST Stock Holding History

Rock Creek Group’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,125	Closed	-$542K	–	221
2021 Q4	$542K	Buy	+9,125	New	+$937K	0.08%	81

Other funds holding TWST

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Rock Creek Group's TWST Position: Q1 2022 in Review

Rock Creek Group sold out of Twist Bioscience (TWST) in Q1 2022, closing a stake of 9,125 shares — an estimated $542K sold.

Rock Creek Group first reported a position in TWST in Q4 2021 and held it in 1 quarter. The position peaked at $542K in Q4 2021. 212 funds tracked by Wall St. Rank hold TWST as of Q1 2022.

Rock Creek Group reported no remaining Twist Bioscience position as of Q1 2022 after selling out during the quarter.
Rock Creek Group sold 9,125 Twist Bioscience shares in Q1 2022, an estimated $542K.
Rock Creek Group first reported a position in Twist Bioscience in Q4 2021 and held it in 1 quarter.
Rock Creek Group's Twist Bioscience position peaked at $542K in Q4 2021.
212 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2022.

Based on Rock Creek Group's 13F filing for Q1 2022, filed 11 May 2022.